Clinical Trial Update: Evaluation of Safety and Effectiveness of the EMBLOK EPS During TAVR [NA]

View source ↗

Summary

Clinical trial update on the safety and effectiveness evaluation of the EMBLOK EPS embolic protection system during transcatheter aortic valve replacement (TAVR…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Valve Disease
• Aortic Valve Insufficiency
• Aortic Valve Stenosis

Drugs mentioned

• EMBLOK EPS

Snippet

Sponsor: Emblok, Inc. | Conditions: Aortic Valve Stenosis, Aortic Valve Disease | NA | Status: ACTIVE_NOT_RECRUITING